176 related articles for article (PubMed ID: 35402225)
1. RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells.
Mijit M; Wireman R; Armstrong L; Gampala S; Hassan Z; Schneeweis C; Schneider G; Zhang C; Fishel ML; Kelley MR
Front Oncol; 2022; 12():826617. PubMed ID: 35402225
[TBL] [Abstract][Full Text] [Related]
2. Activation of the integrated stress response (ISR) pathways in response to Ref-1 inhibition in human pancreatic cancer and its tumor microenvironment.
Mijit M; Boner M; Cordova RA; Gampala S; Kpenu E; Klunk AJ; Zhang C; Kelley MR; Staschke KA; Fishel ML
Front Med (Lausanne); 2023; 10():1146115. PubMed ID: 37181357
[TBL] [Abstract][Full Text] [Related]
3. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
4. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
[TBL] [Abstract][Full Text] [Related]
5. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
Logsdon DP; Shah F; Carta F; Supuran CT; Kamocka M; Jacobsen MH; Sandusky GE; Kelley MR; Fishel ML
Sci Rep; 2018 Sep; 8(1):13759. PubMed ID: 30214007
[TBL] [Abstract][Full Text] [Related]
6. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer.
Mijit M; Kpenu E; Chowdhury NN; Gampala S; Wireman R; Liu S; Babb O; Georgiadis MM; Wan J; Fishel ML; Kelley MR
Redox Biol; 2024 Feb; 69():102977. PubMed ID: 38056311
[TBL] [Abstract][Full Text] [Related]
7. New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.
Gampala S; Moon HR; Wireman R; Peil J; Kiran S; Mitchell DK; Brewster K; Mang H; Masters A; Bach C; Smith-Kinnamen W; Doud EH; Rai R; Mosley AL; Quinney SK; Clapp DW; Hamdouchi C; Wikel J; Zhang C; Han B; Georgiadis MM; Kelley MR; Fishel ML
Pharmacol Res; 2024 Mar; 201():107092. PubMed ID: 38311014
[TBL] [Abstract][Full Text] [Related]
8. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
[TBL] [Abstract][Full Text] [Related]
9. Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.
Sardar Pasha SPB; Sishtla K; Sulaiman RS; Park B; Shetty T; Shah F; Fishel ML; Wikel JH; Kelley MR; Corson TW
J Pharmacol Exp Ther; 2018 Oct; 367(1):108-118. PubMed ID: 30076264
[TBL] [Abstract][Full Text] [Related]
10. Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: exploiting this novel finding as a potential target.
Gampala S; Shah F; Lu X; Moon HR; Babb O; Umesh Ganesh N; Sandusky G; Hulsey E; Armstrong L; Mosely AL; Han B; Ivan M; Yeh JJ; Kelley MR; Zhang C; Fishel ML
J Exp Clin Cancer Res; 2021 Aug; 40(1):251. PubMed ID: 34376225
[TBL] [Abstract][Full Text] [Related]
11. Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells.
Champion JD; Dodd KM; Lam HC; Alzahrani MAM; Seifan S; Rad E; Scourfield DO; Fishel ML; Calver BL; Ager A; Henske EP; Davies DM; Kelley MR; Tee AR
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551683
[TBL] [Abstract][Full Text] [Related]
12. Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer.
Geismann C; Grohmann F; Dreher A; Häsler R; Rosenstiel P; Legler K; Hauser C; Egberts JH; Sipos B; Schreiber S; Linkermann A; Hassan Z; Schneider G; Schäfer H; Arlt A
Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):782-796. PubMed ID: 28188806
[TBL] [Abstract][Full Text] [Related]
13. APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells.
McIlwain DW; Fishel ML; Boos A; Kelley MR; Jerde TJ
Oncotarget; 2018 Feb; 9(13):10962-10977. PubMed ID: 29541389
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
[TBL] [Abstract][Full Text] [Related]
15. APE1/Ref-1 as a Novel Target for Retinal Diseases.
Heisel C; Yousif J; Mijiti M; Charizanis K; Brigell M; Corson TW; Kelley MR
J Cell Signal; 2021; 2(2):133-138. PubMed ID: 34322687
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen peroxide activates APE1/Ref-1 via NF-κB and Parkin: a role in liver cancer resistance to oxidative stress.
Siswanto FM; Okukawa K; Tamura A; Oguro A; Imaoka S
Free Radic Res; 2023 Dec; 57(3):223-238. PubMed ID: 37364176
[TBL] [Abstract][Full Text] [Related]
17. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis.
Sahakian L; Filippone RT; Stavely R; Robinson AM; Yan XS; Abalo R; Eri R; Bornstein JC; Kelley MR; Nurgali K
Inflamm Bowel Dis; 2021 Feb; 27(3):388-406. PubMed ID: 32618996
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of Ref-1 and STAT3 leads to synergistic tumour inhibition in multiple cancers using 3D and in vivo tumour co-culture models.
Caston RA; Shah F; Starcher CL; Wireman R; Babb O; Grimard M; McGeown J; Armstrong L; Tong Y; Pili R; Rupert J; Zimmers TA; Elmi AN; Pollok KE; Motea EA; Kelley MR; Fishel ML
J Cell Mol Med; 2021 Jan; 25(2):784-800. PubMed ID: 33274592
[TBL] [Abstract][Full Text] [Related]
20. APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma - characterizing gene expression changes and identifying novel pathways using single-cell RNA sequencing.
Shah F; Goossens E; Atallah NM; Grimard M; Kelley MR; Fishel ML
Mol Oncol; 2017 Dec; 11(12):1711-1732. PubMed ID: 28922540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]